ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
Biotechnologia Acta V. 14, No 4, 2021
Р. 64-69, Bibliography 14, English
Universal Decimal Classification: 616.13. 002+541.183
https://doi.org/10.15407.biotech14.04.064
ON THE POSSIBILITY OF USING CARBON ENTEROSORBENTS TO NORMALIZE CHOLESTEROL METABOLISM
N. V. Sych, L. I. Kotyns’ka, V. M. Vikarchuk, I. A. Farbun
Institute for Sorption and Endoecology Problems of the National Academy of Sciences of Ukraine, Kyiv
The creation of effective drugs for the prevention and treatment of atherosclerosis is one of the urgent interdisciplinary tasks for modern chemistry and pharmacology. Given the role of hypercholesterolemia in the development of this disease, it is necessary to remove excess amounts of cholesterol from the body. As an alternative to means of lowering total cholesterol and low-density lipoprotein (LDL) cholesterol, the possibility of using carbon enterosorbents for efferent therapy is considered.
Aim. The purpose of the study was to evaluate the sorption capacity of the adsorbents developed by authors in terms of the possibility of cholesterol adsorption.
Methods. Using the spectrophotometric method, the sorption of cholesterol on samples of adsorbents obtained by chemical activation of waste from the processing of lignocellulosic raw materials — dogwood and coffee residue has been studied.
Results. A comparison of sorption isotherms with the isotherm obtained on the industrial adsorbent SORBEX has been performed. It was shown that the adsorption capacity of carbon adsorbents is primarily determined by their porous structure. The highest sorption values (7,3 mg/g) have been revealed by the sorption material obtained by chemical activation of cornel seed, an intermediate position (6,3 mg/g) is occupied by the adsorbent obtained from the coffee residue. Industrial carbon SORBEX has the lowest sorption values (5,3 mg/g).
Conclusions. Calculations by Langmuir’s and Freundlich’s models testify about the accordance of the experimental data to Langmuir’s model. The use of the obtained activated carbons may be one of the effective alternative ways to lower blood cholesterol.
Key words: cholesterol; atherosclerosis; low-density lipoprotein (LDL); enterosorbents; metabolism.
© Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, 2021
References
1. Brugts J. J., Yetgin T., Hoeks S. E., Gotto A. M., Shepherd J., Westendorp R. G., de Craen A. J., Knopp R. H., Nakamura H., Ridker, P., van Domburg R., Deckers J. W. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: metaanalysis of randomised controlled trials. BMJ. 2009, V. 338, P. b2376. https://doi.org/10.1136/bmj.b2376
2. Pandor A., Ara R. M., Tumur I., Wilkinson A. J., Paisley S., Duenas A., Durrington P. N., Chilcott J. Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials. J. Intern. Med. 2009, V. 265, P. 568–580. https://doi.org/10.1111/j.1365-2796.2008.02062.x
3. Mikhailidis D. P., Sibbring G. C., Ballantyne C. M., Davies G. M., Catapano A. L. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr. Med. Res. Opin. 2007, V. 23, P. 2009–2026. https://doi.org/10.1185/030079907X210507
4. Jeffrey S. Cohn, Alvin Kamili, Elaine Wat, Rosanna W. S. Chung and Sally Tandy Phospholipids and Intestinal Cholesterol Absorption. Nutrients. 2010, V. 2, P. 116–127. https://doi.org/10.3390/nu2020116
5. Yu H., Fu G., Zhao J., Liu L., He B. Synthesis and in vitro sorption properties of PAA-grafted cellulose beads for selective binding of LDL. Artif Cells Blood Substit Immobil. Biotechnol. 2006, 34 (5), 501–513. https://doi.org/10.1080/10731190600862795
6. Wang S., Guo X., Wang L., Wang W., Yu Y. Effect of PEG spacer on cellulose adsorbent for the removal of low density lipoprotein-cholesterol. Artif Cells Blood Substit Immobil. Biotechnol. 2006, 34 (1), 99–110. PMID: 16519407 https://doi.org/10.1080/10731190500430222
7. Asano T., Tsuru K., Hayakawa S., Osaka A. Low density lipoprotein adsorption on sol-gel derived alumina for blood purification therapy. Biomed. Mater. Eng. 2008, 18 (3), 161–170. PMID: 18725696 https://doi.org/10.3233/BME-2008-0519
8. Claus-Chr. Heuck Polyacrylate adsorbents for the selective adsorption of cholesterol-rich lipoproteins from plasma or blood. Ger. Med. Sci. 2011, V. 9, Doc02. https://doi.org/10.3205/000125
9. Lysenkova A. V., Filippova V. A., Prischepova L. V., Odintsova M. V. Theoretical bases of adsorption therapy of atherosclerosis. Problemy zdorovya i ecologii. 2010, N 1, 101–104. (In Russian).
10. Devi S., Singh R. Antioxidant and antihypercholesterolemic potential of Vitis vinifera leaves. Pharmacol. J. 2017, 9 (4), 565–572. https://doi.org/10.5530/pj.2017.4.90
11. Gunawan Pasaribu, Totok K. Waluyo, Gustan Pari, Novitri Hastuti. The effectiveness of glucomannan and nano activated-carbon as hypercholesterollowering agents. Indonesian J. Forestry Res. 2020, 7 (2), 155–164. https://doi.org/10.20886/ijfr.2020.7.2.155-164
12. Liu Z., Tabakman S., Welsher K. Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res. 2010, 2 (2), 85–120. https://doi.org/10.1007/s12274-009-9009-8
13. Shao W., Arghya P., Yiyong M., Rodes L., Prakash S. Carbon nanotubes for use in medicine: Potentials and limitations. Syntheses and Applications of Carbon Nanotubes and Their Composites. 2013. https://doi.org/10.5772/51785
14. Mashkour M. S., Alhassan-Almatori N. A., Brbber A. M. Spectrophotometric determination of Cholesterol by using procaine as coupling reagent. Int. J. ChemTech. Res. 2017, 10 (2), 630–640.